Funding also remains very consistent for this company as they begin to near the larger animal studies and beyond. It is my understanding that one of the primary objectives of the U.S. expansion for this company is to engage with and solidify funding from healthcare industry investors as the company begins to focus more and more on the business aspect of the company (which will be incredibly important in the near future). This running in parallel with the Perth headquarters focusing primarily on the scientific developments is a great way of the company moving forward in both scientific and business aspects.
PYC Price at posting:
15.5¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)